DK0675956T3 - Nyt protein fra urin betegnet komponent B - Google Patents

Nyt protein fra urin betegnet komponent B

Info

Publication number
DK0675956T3
DK0675956T3 DK94904167T DK94904167T DK0675956T3 DK 0675956 T3 DK0675956 T3 DK 0675956T3 DK 94904167 T DK94904167 T DK 94904167T DK 94904167 T DK94904167 T DK 94904167T DK 0675956 T3 DK0675956 T3 DK 0675956T3
Authority
DK
Denmark
Prior art keywords
urine
pct
new protein
designated component
sec
Prior art date
Application number
DK94904167T
Other languages
English (en)
Inventor
Antonino Sirna
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0675956T3 publication Critical patent/DK0675956T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK94904167T 1992-12-22 1993-12-21 Nyt protein fra urin betegnet komponent B DK0675956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920919A IT1257184B (it) 1992-12-22 1992-12-22 Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
PCT/EP1993/003645 WO1994014959A1 (en) 1992-12-22 1993-12-21 New protein from urine named component b

Publications (1)

Publication Number Publication Date
DK0675956T3 true DK0675956T3 (da) 2003-07-07

Family

ID=11401349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94904167T DK0675956T3 (da) 1992-12-22 1993-12-21 Nyt protein fra urin betegnet komponent B

Country Status (19)

Country Link
US (1) US5908827A (da)
EP (1) EP0675956B1 (da)
JP (1) JP3025014B2 (da)
KR (1) KR100193107B1 (da)
AT (1) ATE236976T1 (da)
AU (1) AU690093B2 (da)
CA (1) CA2151156A1 (da)
DE (1) DE69332861T2 (da)
DK (1) DK0675956T3 (da)
ES (1) ES2193152T3 (da)
FI (2) FI114478B (da)
IL (1) IL108149A (da)
IT (1) IT1257184B (da)
NO (1) NO315800B1 (da)
PT (1) PT675956E (da)
RU (1) RU2177480C2 (da)
UA (1) UA46702C2 (da)
WO (1) WO1994014959A1 (da)
ZA (1) ZA939621B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895478B1 (en) * 1996-04-24 2003-03-12 Applied Research Systems ARS Holding N.V. Component b as cicatrizant
AU8536698A (en) * 1997-06-09 1998-12-30 Wolf-Georg Forssmann Lus-1 human protein, its production and use
ATE224200T1 (de) * 1998-07-09 2002-10-15 Applied Research Systems Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
DE602004031003D1 (de) * 2003-04-16 2011-02-24 Merck Serono Sa Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden
US7343581B2 (en) * 2005-06-27 2008-03-11 Tela Innovations, Inc. Methods for creating primitive constructed standard cells
US7590968B1 (en) 2006-03-01 2009-09-15 Tela Innovations, Inc. Methods for risk-informed chip layout generation
US9009641B2 (en) 2006-03-09 2015-04-14 Tela Innovations, Inc. Circuits with linear finfet structures
US9563733B2 (en) 2009-05-06 2017-02-07 Tela Innovations, Inc. Cell circuit and layout with linear finfet structures
US7763534B2 (en) 2007-10-26 2010-07-27 Tela Innovations, Inc. Methods, structures and designs for self-aligning local interconnects used in integrated circuits
US7956421B2 (en) 2008-03-13 2011-06-07 Tela Innovations, Inc. Cross-coupled transistor layouts in restricted gate level layout architecture
US7943967B2 (en) 2006-03-09 2011-05-17 Tela Innovations, Inc. Semiconductor device and associated layouts including diffusion contact placement restriction based on relation to linear conductive segments
US8658542B2 (en) 2006-03-09 2014-02-25 Tela Innovations, Inc. Coarse grid design methods and structures
US8653857B2 (en) 2006-03-09 2014-02-18 Tela Innovations, Inc. Circuitry and layouts for XOR and XNOR logic
US8541879B2 (en) 2007-12-13 2013-09-24 Tela Innovations, Inc. Super-self-aligned contacts and method for making the same
US8245180B2 (en) 2006-03-09 2012-08-14 Tela Innovations, Inc. Methods for defining and using co-optimized nanopatterns for integrated circuit design and apparatus implementing same
US8448102B2 (en) 2006-03-09 2013-05-21 Tela Innovations, Inc. Optimizing layout of irregular structures in regular layout context
US7917879B2 (en) * 2007-08-02 2011-03-29 Tela Innovations, Inc. Semiconductor device with dynamic array section
US8225239B2 (en) 2006-03-09 2012-07-17 Tela Innovations, Inc. Methods for defining and utilizing sub-resolution features in linear topology
US8225261B2 (en) 2006-03-09 2012-07-17 Tela Innovations, Inc. Methods for defining contact grid in dynamic array architecture
US8839175B2 (en) 2006-03-09 2014-09-16 Tela Innovations, Inc. Scalable meta-data objects
US7932545B2 (en) 2006-03-09 2011-04-26 Tela Innovations, Inc. Semiconductor device and associated layouts including gate electrode level region having arrangement of six linear conductive segments with side-to-side spacing less than 360 nanometers
US7446352B2 (en) * 2006-03-09 2008-11-04 Tela Innovations, Inc. Dynamic array architecture
US9230910B2 (en) 2006-03-09 2016-01-05 Tela Innovations, Inc. Oversized contacts and vias in layout defined by linearly constrained topology
US9035359B2 (en) 2006-03-09 2015-05-19 Tela Innovations, Inc. Semiconductor chip including region including linear-shaped conductive structures forming gate electrodes and having electrical connection areas arranged relative to inner region between transistors of different types and associated methods
US8247846B2 (en) 2006-03-09 2012-08-21 Tela Innovations, Inc. Oversized contacts and vias in semiconductor chip defined by linearly constrained topology
US7577049B1 (en) 2006-08-08 2009-08-18 Tela Innovations, Inc. Speculative sense enable tuning apparatus and associated methods
US7979829B2 (en) * 2007-02-20 2011-07-12 Tela Innovations, Inc. Integrated circuit cell library with cell-level process compensation technique (PCT) application and associated methods
US8286107B2 (en) 2007-02-20 2012-10-09 Tela Innovations, Inc. Methods and systems for process compensation technique acceleration
US8667443B2 (en) 2007-03-05 2014-03-04 Tela Innovations, Inc. Integrated circuit cell library for multiple patterning
RU2562108C2 (ru) * 2007-09-20 2015-09-10 Коммонвелт Сайентифик Энд Индастриал Рисерч Органайзейшн Новые цитокины птиц и кодирующие их генетические последовательности
EP2194126B1 (en) * 2007-10-15 2014-01-15 Chugai Seiyaku Kabushiki Kaisha Method of constructing cells with high productivity of foreign protein
US8453094B2 (en) 2008-01-31 2013-05-28 Tela Innovations, Inc. Enforcement of semiconductor structure regularity for localized transistors and interconnect
US7939443B2 (en) 2008-03-27 2011-05-10 Tela Innovations, Inc. Methods for multi-wire routing and apparatus implementing same
EP2321748B1 (en) 2008-07-16 2017-10-04 Tela Innovations, Inc. Methods for cell phasing and placement in dynamic array architecture and implementation of the same
US9122832B2 (en) 2008-08-01 2015-09-01 Tela Innovations, Inc. Methods for controlling microloading variation in semiconductor wafer layout and fabrication
GB0820631D0 (en) * 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
EP2239322A1 (en) * 2009-04-07 2010-10-13 Basf Se Use of enzymes to reduce formaldehyde from formaldehyde-containing products
US8661392B2 (en) 2009-10-13 2014-02-25 Tela Innovations, Inc. Methods for cell boundary encroachment and layouts implementing the Same
US9159627B2 (en) 2010-11-12 2015-10-13 Tela Innovations, Inc. Methods for linewidth modification and apparatus implementing the same
EP2740485B1 (en) * 2012-12-07 2018-10-31 Brightpulse Holding LTD. Protein slurp-1 for use in the treatment of ocular diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359415A (en) * 1981-06-03 1982-11-16 University Of Tennessee Research Corporation Isolation of an antineoplastic protein fraction and an antineoplastic peptide fraction from human urine
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5298604A (en) * 1992-07-27 1994-03-29 Sloane Nathan H Parital primary amino acid sequence of the antineoplastic protein (ANUP); a cytokine present in granulocytes

Also Published As

Publication number Publication date
FI114478B (fi) 2004-10-29
IL108149A (en) 2005-05-17
WO1994014959A1 (en) 1994-07-07
AU5833594A (en) 1994-07-19
CA2151156A1 (en) 1994-07-07
FI953091A0 (fi) 1995-06-21
PT675956E (pt) 2003-07-31
FI953091A (fi) 1995-06-21
ZA939621B (en) 1995-06-22
NO952494D0 (no) 1995-06-21
NO315800B1 (no) 2003-10-27
FI116059B (fi) 2005-09-15
ITRM920919A0 (it) 1992-12-22
DE69332861D1 (de) 2003-05-15
IL108149A0 (en) 1994-04-12
JP3025014B2 (ja) 2000-03-27
ATE236976T1 (de) 2003-04-15
DE69332861T2 (de) 2004-01-29
KR100193107B1 (ko) 1999-06-15
KR950704486A (ko) 1995-11-20
AU690093B2 (en) 1998-04-23
UA46702C2 (uk) 2002-06-17
RU2177480C2 (ru) 2001-12-27
IT1257184B (it) 1996-01-10
EP0675956B1 (en) 2003-04-09
FI20040608A (fi) 2004-04-29
ITRM920919A1 (it) 1994-06-22
NO952494L (no) 1995-08-21
JPH08509359A (ja) 1996-10-08
EP0675956A1 (en) 1995-10-11
ES2193152T3 (es) 2003-11-01
US5908827A (en) 1999-06-01

Similar Documents

Publication Publication Date Title
DK0675956T3 (da) Nyt protein fra urin betegnet komponent B
ATE215966T1 (de) Interleukin-1-inhibitoren
DK0612322T3 (da) Fremgangsmåde til adskillelse af 5-methyl-tetrahydrofolsyre
NO974514D0 (no) Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein
DK0687260T3 (da) Fremgangsmåde til fremstillingen af 9-desoxotaxaner
ES2131528T3 (es) Nuevos polipeptidos y su uso.
GR3025698T3 (en) NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES.
DK455088D0 (da) Syntetiske receptoranaloger
DK0630365T3 (da) Fremgangsmåde til fremstilling af beta-phenylisoserin og analoge deraf
ES2145772T3 (es) Uso de un complejo de ibuprofeno-beta-ciclodextrina para administracion oral.
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DK0937094T3 (da) Fremgangsmåde til fremstilling af ivermectin
DK0909268T3 (da) Fremgangsmåde til fremstilling af substituerede anthraquinoner og anvendelse til fremstilling af rheiner
ATE176244T1 (de) Prozess zur reinigung von natürlichem lungen- surfactant mittels superkritischer flüssigkeiten
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.
ATE328088T1 (de) Transketolase-verwandtes protein
SE9102960L (sv) Saett och anordning foer utsaettning av fiskrom
NO974687D0 (no) Kondenserte <beta>-carboliner